TCI Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

TCI Wealth Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-240	Closed	-$7.22K	–	341
2023 Q1	$7.22K	Hold	240	–	–	﹤0.01%	1286
2022 Q4	$6.78K	Sell	240 -49	-17%	-$1.55K	﹤0.01%	1336
2022 Q3	$10K	Hold	289	–	–	﹤0.01%	987
2022 Q2	$9K	Hold	289	–	–	﹤0.01%	1056
2022 Q1	$13K	Sell	289 -1	-0.3%	-$48	﹤0.01%	912
2021 Q4	$18K	Buy	290 +5	+2%	+$346	﹤0.01%	752
2021 Q3	$21K	Buy	285 +10	+4%	+$839	﹤0.01%	664
2021 Q2	$25K	Buy	275 +30	+12%	+$2.55K	﹤0.01%	551
2021 Q1	$22K	Buy	245 +138	+129%	+$13.7K	0.01%	542
2020 Q4	$10K	Buy	107 +47	+78%	+$3.75K	﹤0.01%	640
2020 Q3	$4K	Hold	60	–	–	﹤0.01%	814
2020 Q2	$3K	Sell	60 -20	-25%	-$858	﹤0.01%	867
2020 Q1	$3K	Buy	+80	New	+$2.67K	﹤0.01%	830

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

TCI Wealth Advisors's ARKG Position: Q2 2023 in Review

TCI Wealth Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2023, closing a stake of 240 shares — an estimated $7.22K sold.

TCI Wealth Advisors first reported a position in ARKG in Q1 2020 and held it in 13 quarters. The position peaked at $25K in Q2 2021. 290 funds tracked by Wall St. Rank hold ARKG as of Q2 2023.

TCI Wealth Advisors reported no remaining ARK Genomic Revolution ETF position as of Q2 2023 after selling out during the quarter.
TCI Wealth Advisors sold 240 ARK Genomic Revolution ETF shares in Q2 2023, an estimated $7.22K.
TCI Wealth Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2020 and held it in 13 quarters.
TCI Wealth Advisors's ARK Genomic Revolution ETF position peaked at $25K in Q2 2021.
290 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.